Trualt Bioenergy Intrinsic Value
Trualt Bioenergy (TRUALT) median intrinsic value is ₹333.45 from 9 valuation models (range ₹177–₹520), vs current price ₹428.95 — -22.3% downside (Trading Above Calculated Value), margin of safety -28.6%. Analyse Trualt Bioenergy shareholding analysis to track promoter, FII and institutional holdings.
TRUALT Valuation Methods Summary — DCF, Graham Number & P/E
Trualt Bioenergy intrinsic value across 9 models vs current price ₹428.95 — upside/downside and value range per method. Read TRUALT dividend growth for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹335.52 | ₹268.42 - ₹402.62 | -21.8% | EPS: ₹27.96, Sector P/E: 12x |
| Book Value Method | asset | ₹176.74 | ₹159.07 - ₹194.41 | -58.8% | Book Value/Share: ₹176.74, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹233.30 | ₹209.97 - ₹256.63 | -45.6% | Revenue/Share: ₹291.63, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹418.60 | ₹376.74 - ₹460.46 | -2.4% | EBITDA: ₹600.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹519.64 | ₹415.71 - ₹623.57 | +21.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹178.94 | ₹161.05 - ₹196.83 | -58.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹230.39 | ₹207.35 - ₹253.43 | -46.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹397.21 | ₹357.49 - ₹436.93 | -7.4% | ROE: 16.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹333.45 | ₹300.11 - ₹366.80 | -22.3% | EPS: ₹27.96, BVPS: ₹176.74 |
TRUALT Intrinsic Value vs Market Price — All Valuation Models
Trualt Bioenergy fair value range ₹177–₹520 vs current market price ₹428.95 across 9 valuation models. For current market price and key ratios, visit Trualt Bioenergy share price screener.
TRUALT Intrinsic Value Analysis — Undervalued or Overvalued?
Trualt Bioenergy median intrinsic value ₹333.45, current price ₹428.95 — Trading Above Calculated Value by 22.3%, margin of safety -28.6%.
What is the intrinsic value of TRUALT?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Trualt Bioenergy (TRUALT) is ₹333.45 (median value). With the current market price of ₹428.95, this represents a -22.3% variance from our estimated fair value.
The valuation range spans from ₹176.74 to ₹519.64, indicating ₹176.74 - ₹519.64.
Is TRUALT undervalued or overvalued?
Based on our multi-method analysis, Trualt Bioenergy (TRUALT) appears to be trading above calculated value by approximately 22.3%.
TRUALT Financial Health — Key Ratios vs Industry Benchmarks
Trualt Bioenergy financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.33 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 16.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
TRUALT Cash Flow Quality — Operating & Free Cash Flow
Trualt Bioenergy operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹329 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹36 Cr | ₹-156 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹234 Cr | ₹-341 Cr | Positive Operating Cash Flow | 6/10 |